The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Patel
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.4 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ms. Payal Bhumishth Patel, a promoter of Evoq Remedies Ltd, sold 14,40,000 equity shares (5.78% of the company's paid-up capital) on 17th October 2025 through the stock exchange (open market). Her holding in the company dropped sharply from 15,00,071 shares (6.02%) to just 60,071 shares (0.24%). The transaction was disclosed under Regulation 29(2) of SEBI (SAST) Regulations, 2011, and the company has a total equity share capital of 2,49,00,000 shares of Rs. 10 each. This represents a near-complete exit by this particular promoter from the company.
A 5.78% open-market sell-off by a promoter in a single day is a strongly negative signal for retail investors, often suggesting the promoter sees limited near-term value or needs liquidity. The stock may face selling pressure and lower investor confidence in the short term.